The majority of data supported that TM6SF2 loss-of-function alters lipid metabolism and increases the susceptibility to NAFLD spectrum [89,94,99], although its association fibrosis and HCC is still controversial [86,99,100]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.